Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, Two-Arm, Controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal (IVT) Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity (ROP)

NCT04004208 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04004208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, Two-Arm, Controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal (IVT) Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity (ROP)
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
September 25, 2019
Completion date
February 12, 2021
Enrollment
113 (actual)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity (rop)